By Stuart CondieSYDNEY--Cochlear shares jumped in early trade Thursday after the hearing-implant manufacturer said sales had been stronger than anticipated so far in its 2024 fiscal year. The stock surged as much as 6.7% after the ASX-listed company said that it anticipates full-year underlying net profit of between 385 million Australian dollars (US$251.0 million) and A$400 million, compared with the A$355 million-A$375 million range it flagged in August.

Source: Wall Street Journal February 08, 2024 03:32 UTC